Brainsway Ltd.

Home » Brainsway Ltd.

IPO

Brainsway Ltd.

We are a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using our proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which we have received marketing authorization from the U.S. Food and Drug Administration (FDA).

Symbol

BWAY

Price Range
$11.94 - $11.94

Final Shares
2,500,000

Effective Date
April 17, 2019

Underwriters
CANTOR FITZGERALD & CO.

To view the prospectus for Brainsway Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253